abstract |
Compounds having the formula I wherein Y, R1, R4, A1, A2 and X2 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication. |